Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
A10 - Interleukin-1 Blockade in ST-segment Elevation in MI
Author(s): Antonio Abbate , Cory Trankle , Leo Buckley , et al Added: 4 years ago

Intervention
Author(s): Zach George Added: 3 years ago

Heart Failure

MI/ACS
Door to Unload in ST-segment elevation MI: Safety and Feasibility Study
Author(s): Perwaiz M Meraj Added: 6 years ago

MI/ACS
Author(s): Petr Kala Added: 3 years ago
Patients suffering acute myocardial infarction with ST-segment elevation (STEMI) require full attention of the whole STEMI network to save their lives and to improve the quality of life after a heart attack. Close cooperation among all stakeholders on a national and regional level has to be established. The emergency medical service (EMS) and direct transportation to the 24 hours a day, seven… View more

Standards & Guidelines

Prevention & Chronic Conditions
Author(s): Matthias Hasun , Franz Weidinger Added: 3 years ago
For ST-segment elevation myocardial infarction (STEMI), there is currently no doubt that primary percutaneous coronary intervention (PPCI) of the infarct related artery (IRA) is the preferred reperfusion strategy.1 In about 50% of cases, STEMI is associated with multivessel coronary artery disease (MVCAD), defined as a ≥50% stenosis in at least one non-infarct related epicardial coronary artery … View more

Prevention & Chronic Conditions
Author(s): Deepak Natarajan Added: 3 years ago
Primary percutaneous coronary intervention (PCI) is the treatment of choice in the management of acute ST-segment elevation myocardial infarction (STEMI). It has been constantly observed that, despite restoring good epicardial flow with PCI, myocardial perfusion at the cellular level remains impaired in nearly 50 % of STEMI patients. This led to the development of a new class of antiplatelet… View more

Anticoagulation

MI/ACS
ESC 18 2018: Report From SCAAR - Prof Elmir Omerovic
Author(s): Elmir Omerovic Added: 5 years ago
Prof Elmir Omerovic (University of Gothenburg, Gothenburg, SE) discusses updatesfrom SCAAR registry- Pretreatment with P2Y12 Receptor Antagonists is not Associated with Improved Clinical Outcomes in UA/NSTEMI. Filmed on-site at ESC2018, Munich. View more

MI/ACS
Author(s): Fizzah A Choudry , Roshan P Weerackody , Daniel A Jones , et al Added: 3 years ago
Over the last few decades, primary percutaneous coronary intervention (PCI) has revolutionised the treatment of ST-elevation myocardial infarction (STEMI) with rapid recanalisation of the infarct-related epicardial vessel, resulting in smaller infarct size and a substantial reduction in adverse clinical endpoints.1,2 However, suboptimal myocardial reperfusion is documented to occur in a… View more

Intervention
Evaluating the Impact of COVID-19 on a Regional pPCI Service
Author(s): Adeogo Akinwale Olusan , Peadar Devlin Added: 2 years ago

COVID-19

MI/ACS